SelectQuote Q1 Revenue Falls 15% but Loss Narrows, FY27 Cash Target Reiterated
SLQT sits 41% above its 52-week low of $0.3.
Summary
SelectQuote posted Q1 FY2027 revenue of $280.0 million, down from $328.8 million a year ago, with the decline spread across Senior (down 14%) and Healthcare Services (down 16%). The loss narrowed: net loss of $20.3 million, or 21 cents a share, versus $30.5 million, and Adjusted EBITDA improved to $(17.0) million from $(32.1) million. Cash used in operations fell to $17.2 million from $21.6 million. Management reiterated full-year FY2027 targets, including over $60 million in operating cash flow, and said the Medicare annual enrollment period has started. The weak spot is volume: Medicare Advantage submitted policies dropped 22% to 54,459 and SelectRx members fell 7% to 99,753, though profit per member rose 60%. This follows the August 10-K that disclosed an NYSE delisting notice and a November 10 shareholder vote on a 1-for-10 to 1-for-20 reverse split — with the stock at $0.42, the split and listing cure remain the dominant overhang. The 8:30 a.m. ET call today is where guidance detail and AEP commentary will land.
At the time of this announcement, SLQT was trading at $0.42 on NYSE in the Finance sector, with a market capitalization of approximately $73.5M. The 52-week trading range was $0.30 to $2.17. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: BusinessWire.